Anime Tokyo Station, an exhibition center for Japanese anime operated by the Tokyo Metropolitan Government and the Association of Japanese Animations, is a facility that promotes the appeal of Japanese anime to the world under the motto "Making ANIME more interesting, Bringing ANIME far into the future." The facility has welcomed numerous visitors from Japan […]
NEW YORK, NY / ACCESS Newswire / August 17, 2025 / If you suffered a loss on your Neogen Corporation (NASDAQ:NEOG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neogen-corporation-lawsuit-submission-form?prid=161940&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / August 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the "Class Period"), of the important September 30, 2025 lead plaintiff deadline. SO WHAT:
Download high-resolution images: https://cutt.ly/IrGBefFJ As Hong Kong's pain management expert,Herbalgy has been serving the community since its founding in 1999. For over 25 years, the brand has been dedicated to promoting healthy living and pain management, with a steadfast commitment to product innovation. By integrating the wisdom of Traditional Chinese Medicine (TCM) into modern life,
NEW YORK, NY / ACCESS Newswire / August 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Luminar Technologies, Inc. (NASDAQ:LAZR) between March 20, 2025 and May 14, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline. SO WHAT:
NEW YORK, NY / ACCESS Newswire / August 17, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=161939&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
(AUST:ALK),(TSX:ALK),(OTC US:ALKEF),(OTCQX:ALKEF), PERTH, Australia, Aug. 17, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKEF) ('Alkane' or 'the Company') is pleased to announce the repayment of the outstanding A$45,000,000 debt in the Macquarie facility established for the expansion of the Company's Tomingley Gold Operations (Tomingley) in Central New South Wales. The
Project Finance Facility Fully Repaid GlobeNewswire August 18, 2025 PERTH, Australia, Aug. 17, 2025 (GLOBE NEWSWIRE) — Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKEF) ('Alkane' or 'the Company') is pleased to announce the repayment of the outstanding A$45,000,000 debt in the Macquarie facility established for the expansion of the Company's Tomingley Gold Operations
NEW YORK, NY / ACCESS Newswire / August 17, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Neogen Corporation (NASDAQ:NEOG) between January 5, 2023 and June 3, 2025, inclusive (the "Class Period"), of the important September 16, 2025 lead plaintiff deadline. SO WHAT:If you purchased
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") announced today that the in-house discovered and developed orexin receptor antagonist DAYVIGO(R)(brand name in China: "DAYVIGO(R) generic name: lemborexant) has launched in China for the treatment of adults with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance. Eisai received approval for DAYVIGO in China